Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-06

Clinical Trial Update: Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 maintenance trial of the probiotic combination of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis for Ulcerative Colitis has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis probiotic (Lactobacillus acidophilus; Bifidobacterium animalis subsp. lactis)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Ulcerative Colitis | Phase 2 | Status: TERMINATED